{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:57:23Z","timestamp":1787921843211,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Dexmedetomidine (Dex) is an attractive agent for procedural sedation due to its unique pharmacodynamic profile, specifically affording predictable sedation without concurrent respiratory depression. However, Dex has previously been reported to prevent or terminate arrhythmias. The purpose of this study was to investigate paroxysmal supraventricular tachycardia (PSVT) inducibility and homeostatic stability during electrophysiology studies (EPSs) and ablation when a standardized Dex protocol was used as the primary sedation agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a retrospective review of 163 consecutive procedures for PSVT ablation that received Dex as the primary sedative with adjunct fentanyl and midazolam boluses (DEX-FENT-MIDAZ). This cohort was compared to 163 consecutive control procedures wherein strictly fentanyl and midazolam were used for sedation. The primary outcome reviewed was PSVT inducibility assessed before ablation. Reviewed secondary outcomes included level of sedation and intraprocedure hemodynamics and oxygenation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The arrhythmia profiles of the DEX-FENT-MIDAZ and control cohorts were very similar. The overall incidence of a \u201cnegative\u201d EPSs in which arrhythmia was not induced was 24% in the DEX-FENT-MIDAZ group and 26% in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .7). Unintended deep sedation was significantly less with DEX-FENT-MIDAZ (4.3% vs 27%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 .0001). However, DEX-FENT-MIDAZ use was associated with a higher incidence of intraprocedure hypotension.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Dex sedation during EPSs is not associated with a reduction in PSVT inducibility. The therapeutic utility of Dex during EPS arises from the predictable sedation Dex affords but is associated with an increased incidence of intraprocedure hypotension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003359","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T10:49:03Z","timestamp":1523530143000},"page":"1529-1535","source":"Crossref","is-referenced-by-count":16,"title":["Dexmedetomidine Sedation for Paroxysmal Supraventricular Tachycardia Ablation Is Not Associated With Alteration of Arrhythmia Inducibility"],"prefix":"10.1213","volume":"129","author":[{"given":"Andrew M.","family":"Slupe","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University (OHSU), Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Minnier","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, OHSU-Portland State University (PSU) School of Public Health, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merritt H.","family":"Raitt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Veterans Affairs Portland Health Care System, Portland, Oregon"},{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatius Gerardo E.","family":"Zarraga","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Veterans Affairs Portland Health Care System, Portland, Oregon"},{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"MacMurdy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Veterans Affairs Portland Health Care System, Portland, Oregon"},{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Jessel","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Veterans Affairs Portland Health Care System, Portland, Oregon"},{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9149(93)90156-7","article-title":"Cardiac electrophysiologic effects of midazolam combined with fentanyl.","volume":"72","author":"Lau","year":"1993","journal-title":"Am J Cardiol"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1540-8183.2001.tb00725.x","article-title":"Conscious sedation with intermittent midazolam and fentanyl in electrophysiology procedures.","volume":"14","author":"Pachulski","year":"2001","journal-title":"J Interv Cardiol"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","article-title":"Paradoxical reactions to benzodiazepines: literature review and treatment options.","volume":"24","author":"Mancuso","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.aco.0000174958.05383.d5","article-title":"Dexmedetomidine in anaesthesia.","volume":"18","author":"Paris","year":"2005","journal-title":"Curr Opin Anaesthesiol"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans.","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0310057X0403200602","article-title":"Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy.","volume":"32","author":"Ickeringill","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1213\/ane.0b013e318186499c","article-title":"Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.","volume":"107","author":"Chrysostomou","year":"2008","journal-title":"Anesth Analg"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.athoracsur.2011.04.099","article-title":"Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations.","volume":"92","author":"Chrysostomou","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1213\/01.ane.0000297421.92857.4e","article-title":"The effects of dexmedetomidine on cardiac electrophysiology in children.","volume":"106","author":"Hammer","year":"2008","journal-title":"Anesth Analg"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/pace.12623","article-title":"Electrocardiographic and electrophysiologic effects of dexmedetomidine on children.","volume":"38","author":"Ergul","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCEP.114.002301","article-title":"Association between perioperative dexmedetomidine and arrhythmias after surgery for congenital heart disease.","volume":"8","author":"Shuplock","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/europace\/eut363","article-title":"Procedural sedation with dexmedetomidine during ablation of atrial fibrillation: a randomized controlled trial.","volume":"16","author":"Sairaku","year":"2014","journal-title":"Europace"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/europace\/eut365","article-title":"Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial.","volume":"16","author":"Cho","year":"2014","journal-title":"Europace"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/europace\/euu332","article-title":"Electrophysiological studies in patients with paroxysmal supraventricular tachycardias but no electrocardiogram documentation: findings from a prospective registry.","volume":"17","author":"Lauschke","year":"2015","journal-title":"Europace"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FJC.0000000000000434","article-title":"Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility.","volume":"68","author":"Sairaku","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1540-8159.1999.tb00629.x","article-title":"Usefulness of intravenous propofol anesthesia for radiofrequency catheter ablation in patients with tachyarrhythmias: infeasibility for pediatric patients with ectopic atrial tachycardia.","volume":"22","author":"Lai","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00000542-199011000-00005","article-title":"Frequent hypoxemia and apnea after sedation with midazolam and fentanyl.","volume":"73","author":"Bailey","year":"1990","journal-title":"Anesthesiology"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1213\/ANE.0000000000001125","article-title":"Risk factors for dexmedetomidine-associated hemodynamic instability in noncardiac intensive care unit patients.","volume":"122","author":"Ice","year":"2016","journal-title":"Anesth Analg"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00000542-200204000-00031","article-title":"Practice guidelines for sedation and analgesia by non-anesthesiologists.","volume":"96","year":"2002","journal-title":"Anesthesiology"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.116.003629","article-title":"Sedation in the electrophysiology laboratory: a multidisciplinary review.","volume":"5","author":"Gerstein","year":"2016","journal-title":"J Am Heart Assoc"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000003359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:25Z","timestamp":1786112365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000003359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003359","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}